Koyfin Home > Directory > Health Care > Aduro Biotech > Total Debt / Capital

Aduro Biotech Total Debt / Capital Chart (ADRO)

Aduro Biotech annual/quarterly Total Debt / Capital from 2013 to 2020.
  • Aduro Biotech Total Debt / Capital for the quarter ending June 06, 2020 was $41m a 29.07% increase of 12m year over year
  • Aduro Biotech Total Debt / Capital for the last 12 months ending June 06, 2020 was $41m a 29.07% increase of 12m year over year
  • Aduro Biotech Annual Total Debt / Capital for 2019 was $34m a -489.38% decrease of -165m from 2018
  • Aduro Biotech Annual Total Debt / Capital for 2013 was $199m a -62.28% decrease of -124m from 2012
  • Aduro Biotech Annual Total Debt / Capital for 2012 was $323m
Other Ratios Metrics:
  • Aduro Biotech Other Liabilities for the quarter ending December 12, 2018 was $192m a 1.13% increase of 2m year over year
  • Aduro Biotech Total Debt / Equity for the quarter ending September 09, 2014 was $4m
View Chart On Koyfin

Quarterly ADRO Total Debt / Capital Data

06/2020$41m
03/2020$36m
12/2019$34m
09/2019$29m
06/2019$25m
03/2019$23m
09/2014$4m
03/2014$199m
12/2013$199m

Annual ADRO Total Debt / Capital Data

2019$34m
2013$199m
2012$323m